Download PDF
Thromb Haemost 1959; 03(02): 237-256
DOI: 10.1055/s-0038-1654385
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus?

A Loeliger
1   Clinic for Internal Medicine (Director: Prof. J. Mulder), University Hospital, Leyden, Holland
,
with the technical assistance of Miss,
E. J. J Alsbach
1   Clinic for Internal Medicine (Director: Prof. J. Mulder), University Hospital, Leyden, Holland
› Author AffiliationsWe wish to thank colleague G. J. Sas, specialist in internal medicine in Dordrecht, for kindly putting his data at our disposal.
Further Information

Publication History

Publication Date:
08 June 2018 (online)

Also available at
   Permissions and Reprints
Zoom Image

Summary

A 35-year old man with lupus erythematosus of the skin is demonstrated, who also shows signs of systemic L. E.: sometimes slightly increased ESR, varying thrombocytopenia, slightly prolonged coagulation and prothrombin time, positive cepnalin-cholesterol flocculation test, biologically false positive syphilis reactions and signs of a slightly increased haemolysis. Electrophoretic examination of the serum proteins presents practically normal values, certainly no hypergammaglobulinaemia. Analytical examination of coagulation reveals hypoprothrombinaemia and an anticoagulant most probably directed against thrombocyte factor 3, intrinsic thromboplastin and tissue thromboplastin. The anticoagulant seems to be only active in the presence of prothrombin. Prothrombin therefore, is considered a co-factor of the anticoagulant. The inactive anticoagulant is localized in the gamma globulins. The possible cause of the hypoprothrombinaemia (immune reaction?) and the data in the literature are discussed.